Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Market indexes were looking like they might fall into the red this afternoon, a half hour before the closing bell, based on news from the White House that +25% tariffs were being set on our ...

Shares of United Parcel Service suffered their worst day ever on Thursday, after the package-delivery giant announced an ...

All three major U.S. stock indexes were higher in late-afternoon trade as focused turned away from Wednesday's Federal Reserve meeting and toward corporate earnings on deck. The S&P 500 index was ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

UPS is cutting its business with Amazon in half by the middle of next year due to profitability concerns, CEO Carol Tomé said ...

Envoy Textiles, the world's first LEED Platinum certified denim manufacturer, has reported a 147% increase in net profit, reaching Tk60 crore in the first half of the current fiscal year. Its revenue ...

Tesla's fourth-quarter earnings missed Wall Street's estimates, but the stock rose on 2025 guidance and plans for robotaxi rides to begin in June.

Let's acknowledge straightaway that this cursory look at some (and only some) of the major regional programs can represent little more than a gesture of respect. As a rule, after all, we're talking ...

Investors punished Microsoft with a 6% share drop on Thursday as hefty AI bets failed to drive a big increase in its cloud ...

Shares in clinical-stage biotechnology company Cargo Therapeutics (CRGX) have plunged after it scrapped trials of a cancer ...

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...